Valuation: Sysmex Corporation

Market Cap 1,274B 8B 7.29B 6.74B 6.09B 11.46B 747B 11.91B 81.44B 32.19B 403B 30B 29.37B P/E 2027 *
30.9x
P/E 2028 * 25.8x
Enterprise Value 1,293B 8.12B 7.4B 6.84B 6.18B 11.63B 758B 12.09B 82.66B 32.67B 409B 30.45B 29.81B EV / Sales 2027 *
2.34x
EV / Sales 2028 * 2.25x
Free-Float
71.34%
Yield 2027 *
1.91%
Yield 2028 * 1.98%
1 day-0.90%
1 week+3.35%
Current month+9.05%
1 month+15.32%
3 months+12.47%
6 months+52.41%
Current year+36.00%
1 week 12.87
Extreme 12.87
13.5
1 month 11.35
Extreme 11.35
13.75
Current year 8.01
Extreme 8.01
13.75
1 year 8.01
Extreme 8.01
13.75
3 years 8.01
Extreme 8.01
22
5 years 8.01
Extreme 8.01
46.27
10 years 8.01
Extreme 8.01
46.27
Manager TitleAgeSince
Chief Executive Officer 77 31/03/2018
Director of Finance/CFO 56 -
President 65 31/03/2026
Director TitleAgeSince
Chairman 77 31/03/2013
Director/Board Member 65 31/05/2019
Director/Board Member 71 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%+3.35% - - 8.13B
-0.11%-4.36%-19.59%+3.29% 181B
-1.26%-0.33%+0.47%+34.74% 125B
+0.39%-0.06%-11.38%+10.13% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-0.62%-0.40%-3.64%+77.85% 66.9B
+0.10%+0.49%+12.09%-7.74% 58.68B
+1.69%+0.09%+4.93%+48.70% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+4.77%+3.97%-1.08% 35.4B
Average +0.24%-0.58%-6.33%+22.99% 87B
Weighted average by Cap. +0.16%-1.52%-10.08%+19.99%

Financials

2027 *2028 *
Net sales 553B 3.48B 3.17B 2.93B 2.64B 4.98B 325B 5.18B 35.39B 13.99B 175B 13.04B 12.76B 579B 3.64B 3.32B 3.07B 2.77B 5.21B 340B 5.42B 37.04B 14.64B 183B 13.64B 13.36B
Net income 39.94B 251M 229M 211M 191M 359M 23.43B 374M 2.55B 1.01B 12.65B 941M 921M 49.78B 313M 285M 264M 238M 448M 29.21B 466M 3.18B 1.26B 15.77B 1.17B 1.15B
Net Debt 19B 119M 109M 101M 90.78M 171M 11.15B 178M 1.21B 480M 6.02B 448M 438M 28.6B 180M 164M 151M 137M 257M 16.78B 268M 1.83B 723M 9.06B 674M 660M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
18/11/26 US$13.26 -0.90% 1,146
17/11/26 US$13.38 +0.90% 32,668
16/11/26 US$13.26 +2.28% 13,510
13/11/26 US$12.97 +0.19% 8,304
12/11/26 US$12.94 +0.86% 25,677
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,115.50JPY
Average target price
2,203.57JPY
Spread / Average Target
+4.16%